Target intelligence / Profile preview

Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1 (PDE1)

Target
PDE1
Molecular classification
Enzyme, Phosphodiesterase, Hydrolase
01

Overview

Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1 (PDE1) is a family of dual-specificity enzymes (comprising PDE1A, PDE1B, and PDE1C) that catalyze the hydrolysis of the intracellular second messengers cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) into their inactive 5'-monophosphate forms. A unique feature of the PDE1 family is its activation by the calcium/calmodulin complex, which directly couples intracellular calcium signaling with cyclic nucleotide degradation. PDE1 is widely expressed in the brain, heart, vascular smooth muscle, and kidneys, playing a critical role in regulating vascular tone, cardiac contractility, neuronal plasticity, and cell proliferation. Dysregulation of PDE1 is implicated in several pathological conditions, including cardiovascular diseases (such as pulmonary arterial hypertension and heart failure), neurodegenerative and neuropsychiatric disorders (such as Parkinson's disease, Alzheimer's disease, and schizophrenia), and autosomal dominant polycystic kidney disease. Pharmacological inhibition of PDE1, using drugs like lenrispodun (ITI-214) and vinpocetine, prevents the breakdown of cAMP and cGMP, thereby enhancing downstream protein kinase A (PKA) and protein kinase G (PKG) signaling. This therapeutic strategy is being actively investigated to improve cognitive function, promote neuroprotection, and induce vasodilation in various clinical settings.

Other names
Calcium/calmodulin-dependent phosphodiesterase 1CaM-PDE 1Phosphodiesterase 1Calcium/calmodulin-dependent cyclic nucleotide phosphodiesterase 1Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1
02

Mechanism of action

Inhibition of cAMP and cGMP hydrolysis, leading to increased intracellular levels of cAMP and cGMP and subsequent activation of protein kinase A (PKA) and protein kinase G (PKG) signaling pathways.

03

Biological functions

Signal transductioncAMP catabolic processcGMP catabolic processCalcium signalingNeuronal plasticityLearning and memoryCell proliferation
04

Disease associations

Cardiovascular diseaseNeurodegenerative diseaseNeurodevelopmental disorderPsychiatric disorderInflammationCancerPolycystic kidney disease
05

Safety considerations

Vasodilation-related side effects such as hypotension, headache, and flushingOff-target effects on other PDE families due to lack of selectivity in older inhibitorsPotential cardiovascular risks including tachycardia or arrhythmiaCentral nervous system side effects such as dizziness or sleep disturbances
06

Interacting drugs

9 more in the full profile.

07

Biomarkers

Intracellular cAMP levelsIntracellular cGMP levelsCREB phosphorylationVascular smooth muscle cell proliferation markers

Beyond the preview

Go deeper on Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1 (PDE1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1 (PDE1).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call